Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
AR/ARv7 Signaling and EPI-001 in TNBC
2026-08-11
This 2025 study links androgen receptor variant 7 (ARv7), particularly nuclear ARv7, with unfavorable outcomes and distant metastasis in triple-negative breast cancer. Using patient pathology, TCGA-BRCA analysis, and MDA-MB-231 functional assays, it shows that Enzalutamide and EPI-001 modulate metastasis and epithelial-to-mesenchymal transition pathways, supporting further study of N-terminal AR blockade.
-
Higher-Concentration LNPs Improve mRNA Performance
2026-08-11
A 2026 Pharmaceutics study shows that concentrated lipid mixtures and RNA inputs can preserve key LNP quality attributes while improving in vivo expression, biodistribution, and storage behavior. Its confined jet-impingement approach offers a process-intensification strategy for higher-throughput mRNA-LNP manufacturing, although formulation-specific and translational limitations remain.
-
PTH (1-34) in Kidney and Bone Translation
2026-08-10
A mechanism-first strategy for using Parathyroid hormone (1-34) (human) to connect receptor signaling, bone metabolism research, serum calcium regulation, and spatially organized kidney assembloid models without overstating the current evidence.
-
Zolmitriptan: 5-HT1B Agonist Research Guide
2026-08-09
Zolmitriptan is a selective serotonin receptor agonist used as a migraine research compound and in cluster headache research. Its principal experimental value is the study of 5-HT1B and 5-HT1D signaling, cranial vasoconstriction, and trigeminal neuropeptide regulation.
-
Potassium Iodide: Research Workflows & Troubleshooting
2026-08-08
Potassium Iodide supports controlled thyroid-biology experiments, iodide supplementation studies, and formulation checks when its role is kept distinct from active immunotherapy components. This practical guide combines solution preparation, assay controls, troubleshooting, and a carefully bounded translation of responsive-liposome research.
-
MnTBAP Chloride: A Redox Assay Decision Guide
2026-08-07
MnTBAP Chloride is a cell-permeable SOD mimetic for investigating mitochondrial superoxide, oxidative injury, and inflammation. This guide translates recent chronic-stress findings into practical assay-design decisions while distinguishing mechanistic evidence from therapeutic interpretation.
-
Methylprednisolone in Osteonecrosis Models: Protocols & Inno
2026-08-07
Harness methylprednisolone’s dual anti-inflammatory and osteoimmunology power for mechanistically precise bone disease models. This guide translates pivotal in vivo findings and advanced troubleshooting into practical, data-backed workflows for translational research.
-
NUAK1 Inhibition Lowers Pathological Tau in Alzheimer’s Mode
2026-08-06
Taylor et al. (2023) demonstrate that the NUAK1/2 inhibitor WZ4003 selectively reduces tau phosphorylation at Ser356—a modification closely linked to Alzheimer’s disease progression—in both mouse and live human brain slice cultures. Their findings clarify the mechanistic role of NUAK1 in tau pathology and provide a translational bridge toward targeted therapeutic strategies.
-
DAF-2 Diacetate: Precision NO Detection in Plant & Cell Rese
2026-08-06
Explore how DAF-2 diacetate empowers sensitive nitric oxide detection in both plant and mammalian systems. This article reveals advanced assay design and deeper mechanistic insights, setting it apart from existing resources.
-
Shionone Activates Mitophagy to Counter Pulmonary Fibrosis
2026-08-05
This study demonstrates that Shionone, a terpenoid from Ligularia fischeri, mitigates pulmonary fibrosis by stimulating mitophagy via the PINK1-Parkin pathway. The findings highlight a novel mechanism that links mitochondrial quality control and redox regulation to anti-fibrotic therapy, offering new directions for pulmonary fibrosis research.
-
H. pylori-Induced HNF4A Silencing Drives EMT in Gastric Canc
2026-08-05
The referenced study elucidates how Helicobacter pylori infection leads to promoter hypermethylation and silencing of the tumor suppressor gene HNF4A in gastric epithelial cells. This epigenetic alteration drives loss of cell polarity and activates EMT signaling, promoting gastric cancer development and metastasis, and highlights the importance of DNA demethylation agents for mechanistic cancer studies.
-
Plerixafor (AMD3100): Protocols for Cancer and Stem Cell Res
2026-08-04
Plerixafor (AMD3100) empowers researchers to dissect CXCL12/CXCR4 signaling in cancer metastasis inhibition, stem cell mobilization, and immune modulation. This guide distills workflow enhancements, troubleshooting, and the latest insights from cutting-edge studies—enabling precise, reproducible results with APExBIO’s trusted reagent.
-
Canagliflozin and Mitochondrial Modulation: New Horizons in
2026-08-04
Explore how Canagliflozin, a potent SGLT2 inhibitor, advances diabetes research by modulating mitochondrial function and structure in renal cells. This in-depth review provides unique mechanistic insights and practical guidance for leveraging Canagliflozin in metabolic disease models.
-
Dual-Action p38α MAPK Inhibition: Mechanism and Implications
2026-08-03
The reference study reveals that certain kinase inhibitors, including those targeting p38α MAPK, not only block kinase activity but also accelerate dephosphorylation by phosphatases via conformational modulation. This dual-action mechanism, resolved at atomic detail, opens new avenues for designing more potent and selective research tools in inflammation and apoptosis studies.
-
Adiponectin Shields Aging Rats from Surgery-Induced Cognitiv
2026-08-03
This study demonstrates that adiponectin administration can reverse cognitive decline following splenectomy in aged rats by inhibiting the TLR4/MyD88/NF-κB pathway, thereby reducing neuroinflammation and oxidative stress. The findings provide mechanistic insights into perioperative neurocognitive disorder (PND) and highlight therapeutic strategies relevant to neuroimmune modulation in aging.